Tissue Repair Ltd (TRP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tissue Repair Ltd (TRP) has a cash flow conversion efficiency ratio of -0.091x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.26 Million ≈ $-891.91K USD) by net assets (AU$13.91 Million ≈ $9.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tissue Repair Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read TRP total liabilities for a breakdown of total debt and financial obligations.
Tissue Repair Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tissue Repair Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nextage Therapeutics Ltd
TA:NXTG
|
0.311x |
|
JLT Mobile Computers AB (publ)
ST:JLT
|
0.071x |
|
Witbe Net SA
PA:ALWIT
|
0.366x |
|
FIREFOX GOLD CORP.
F:FIY
|
N/A |
|
CXApp Inc.
NASDAQ:CXAI
|
-0.181x |
|
Till Capital Ltd
V:TIL
|
-0.014x |
|
Global Interactive Technologies, Inc
NASDAQ:GITS
|
-0.032x |
|
Lion Energy Ltd
AU:LIO
|
-0.111x |
Annual Cash Flow Conversion Efficiency for Tissue Repair Ltd (2020–2025)
The table below shows the annual cash flow conversion efficiency of Tissue Repair Ltd from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see TRP market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$13.91 Million ≈ $9.84 Million |
AU$-3.70 Million ≈ $-2.62 Million |
-0.266x | +3.12% |
| 2024-06-30 | AU$18.04 Million ≈ $12.76 Million |
AU$-4.95 Million ≈ $-3.50 Million |
-0.274x | -41.14% |
| 2023-06-30 | AU$21.88 Million ≈ $15.48 Million |
AU$-4.26 Million ≈ $-3.01 Million |
-0.194x | -24.24% |
| 2022-06-30 | AU$25.34 Million ≈ $17.93 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-0.157x | -396.87% |
| 2021-06-30 | AU$27.07 Million ≈ $19.16 Million |
AU$-852.89K ≈ $-603.47K |
-0.032x | +95.15% |
| 2020-06-30 | AU$999.90K ≈ $707.50K |
AU$-649.98K ≈ $-459.91K |
-0.650x | -- |
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more